BioBoss host, John Simboli, interviewed Intensity Therapeutics’ CEO, Lewis H. Bender in March of 2020.  The two discussed the challenges facing a small company developing a unique approach to treating cancer, leadership, partnerships, the potential benefits of the new therapy and the risks & fears that entrepreneurs face when starting a biotech company.

You can listen to the Podcast by clicking on the Source link below.

Source: BioBoss Link to Podcast of Lewis H. Bender